“The current set up for HS lesion counting in clinical trials and routine practice is far from ideal. Counting multiple lesions in multiple body sites takes time and there is high risk for error. Thalocan’s Lesion Area Mapping Assistant Trial enables sponsors to undertake quality control from the images and site personnel can assess images…
Thalocan Research Innovations has partnered with Arash Mostaghimi, MD, MPA, MPH to develop a comprehensive training for the BETA and BELA to accompany The Severity of Alopecia Tool (SALT), training for a robust and high quality Alopecia assessment curriculum. Our mission is to support clinical raters with a clear understanding of the scoring criteria for…
The fourth in our series of Conversations with Portia Combow and living with HS. Thalocan Research Innovations CEO Eric Zudak and Portia discuss the roadblocks she’s encountered with clinical studies. Watch the full webinar/conversation at www.thalocan.com/webinars/.
The fourth in our series of Conversations with Portia Combow and living with HS. Thalocan Research Innovations CEO Eric Zudak and Portia discuss the roadblocks she’s encountered with clinical studies. Watch the full webinar/conversation at www.thalocan.com/webinars/.
